India’s First Gene Therapy for Cancer Launched

President of India, Smt. Draupadi MurmuIndia’s first launched home gene therapy for cancer IIT Bombay On April 4, 2024. This unprecedented treatment was called ‘CAR-T cell therapy’A major breakthrough in the fight against cancer.

affordable and accessible treatment

Speaking at the event, President Murmu hailed this therapy as a new hope for humanity as it both accessible and affordable, He expressed confidence that the innovative treatment will give new life to countless patients suffering from cancer.

An unprecedented advance in medical science

The President emphasized that CAR-T cell therapy It is considered one of the most unprecedented advancements in medical science. Although it has been available in developed countries for some time, the therapy was extremely expensive and out of reach for most patients around the world. However, newly launched therapy is World’s most affordable CAR-T cell therapy,

‘Make in India’ and ‘Self-reliant India’

President Murmu highlighted that India’s first CAR-T cell therapy is not only an example of the ‘Make in India’ initiative but also a shining example of the ‘Atmanirbhar Bharat’ (self-reliant India) campaign. He praised the development of the therapy as a collaborative effort IIT Bombay, Tata Memorial Hospitaland industry partners immunoact,

Academia-Industry Partnership

The President hailed the partnership between academia and industry as a commendable example which should inspire more such efforts. He also acknowledged IIT Bombay’s focus on research and development over the last three decades, which made this success possible.

benefits from technological revolution

President Murmu expressed confidence that with the knowledge base and skills of the faculty and students of IIT Bombay and other similar institutions, India as a whole will greatly benefit from the ongoing technological revolution.

The launch of India’s first domestic gene therapy for cancer marks an important milestone in the country’s fight against this deadly disease, providing affordable and accessible treatment to patients around the world.

PolicyBazaar sets up wholly owned subsidiary 'PB Pay Pvt Ltd': Expands into payment aggregation services_80.1

Leave a Comment